Igraine (AQSE:KING) Sale Of Property, Plant, Equipment : £ Mil (TTM As of . 20)

View and export this data going back to 2008. Start your Free Trial

What is Igraine Sale Of Property, Plant, Equipment?

Igraine's sale of property, plant, equipment for the six months ended in . 20 was £0.00 Mil. It means Igraine gained £0.00 Mil from selling property, plant, and equipment.

Compared with last quarter (£0.00 Mil in . 20 ), Igraine gained the same money from selling property, plant, and equipment in . 20 (£0.00 Mil).

Igraine Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Igraine's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Igraine Sale Of Property, Plant, Equipment Chart

Igraine Annual Data

Trend

Sale Of Property, Plant, Equipment

Igraine Semi-Annual Data

Sale Of Property, Plant, Equipment

Igraine Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Igraine Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Igraine's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Igraine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Igraine PLC (AQSE:KING) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Primrose Street, 8th Floor, The Broadgate Tower, London, GBR, EC2A 2EW

Website

https://www.igraineplc.com

Igraine PLC is an investment company. Its business investment is to source and develops breakthrough technologies and commercially attractive discoveries in the health, Medtech, Biotech, and life science sectors.